High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina

Ghulam Mohammad, Mohammad Mairaj Siddiquei, Amira Othman, Mohamed Al-Shabrawey, Ahmed M. Abu El-Asrar

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Extrcellular high-mobility group box-1 (HMGB-1) functions as a pro-inflammatory cytokine and exhibits angiogenic effects. The purpose of this study was to investigate the expression of HMGB-1 signaling pathway components in the retinas of diabetic rats and to examine the effect of intravitreal administration of HMGB-1 on the retinas of rats. The retinas of diabetic and intravitreally injected HMGB-1 rats were studied using immunohistochemistry, Western blotting, co-immunoprecipitation and enzyme-linked immunosorbent assay. The effect of HMGB-1 on retinal endothelial cell barrier function was evaluated using electrical cell-substrate impedance sensing system (ECIS). Diabetes induced significant upregulation of the expression of HMGB-1, receptor for advanced glycation end products (RAGE), ERK1/2 and nuclear transcription factor Kappa B (NF-κB), whereas the expression of toll-like receptor 2 (TLR2) and occludin was significantly downregulated. Co-immunoprecipitation studies revealed significant increase in interaction between HMGB-1 and RAGE. HMGB-1 reduced transendothelial electrical resistance of bovine retinal endothelial cells. Intravitreal administration of HMGB-1 to normal rats induced significant upregulation of intercellular adhesion molecule-1 (ICAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), HMGB-1, RAGE, ERK1/2, and NF-κB, and significantly increased retinal vascular permeability, whereas the expression of TLR2 and occludin was downregulated. Oral administration of glycyrrhizin, a specific inhibitor of HMGB-1, attenuated diabetes-induced upregulation of HMGB-1 expression, NF-κB activation and downregulation of occludin expression. Our findings provide evidence that in the diabetic retina, HMGB-1 possibly interacts with RAGE and activates ERK1/2 and NF-κB to generate an inflammatory response and disrupt retinal vascular barrier.

Original languageEnglish (US)
Pages (from-to)101-109
Number of pages9
JournalExperimental eye research
Volume107
DOIs
StatePublished - Feb 1 2013

Fingerprint

HMGB1 Protein
Retinal Vessels
Occludin
Retina
Toll-Like Receptor 2
Up-Regulation
Down-Regulation
Intercellular Adhesion Molecule-1
Electric Impedance
Immunoprecipitation
Endothelial Cells
Glycyrrhizic Acid
NF-kappa B
Capillary Permeability
Oral Administration
Transcription Factors
Western Blotting
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
Cytokines

Keywords

  • Diabetes
  • HMGB-1
  • Inflammation
  • RAGE
  • Retina
  • Vascular permeability

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. / Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M.

In: Experimental eye research, Vol. 107, 01.02.2013, p. 101-109.

Research output: Contribution to journalArticle

@article{17fa7d0cd47147b38a006e9272b2cacd,
title = "High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina",
abstract = "Extrcellular high-mobility group box-1 (HMGB-1) functions as a pro-inflammatory cytokine and exhibits angiogenic effects. The purpose of this study was to investigate the expression of HMGB-1 signaling pathway components in the retinas of diabetic rats and to examine the effect of intravitreal administration of HMGB-1 on the retinas of rats. The retinas of diabetic and intravitreally injected HMGB-1 rats were studied using immunohistochemistry, Western blotting, co-immunoprecipitation and enzyme-linked immunosorbent assay. The effect of HMGB-1 on retinal endothelial cell barrier function was evaluated using electrical cell-substrate impedance sensing system (ECIS). Diabetes induced significant upregulation of the expression of HMGB-1, receptor for advanced glycation end products (RAGE), ERK1/2 and nuclear transcription factor Kappa B (NF-κB), whereas the expression of toll-like receptor 2 (TLR2) and occludin was significantly downregulated. Co-immunoprecipitation studies revealed significant increase in interaction between HMGB-1 and RAGE. HMGB-1 reduced transendothelial electrical resistance of bovine retinal endothelial cells. Intravitreal administration of HMGB-1 to normal rats induced significant upregulation of intercellular adhesion molecule-1 (ICAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), HMGB-1, RAGE, ERK1/2, and NF-κB, and significantly increased retinal vascular permeability, whereas the expression of TLR2 and occludin was downregulated. Oral administration of glycyrrhizin, a specific inhibitor of HMGB-1, attenuated diabetes-induced upregulation of HMGB-1 expression, NF-κB activation and downregulation of occludin expression. Our findings provide evidence that in the diabetic retina, HMGB-1 possibly interacts with RAGE and activates ERK1/2 and NF-κB to generate an inflammatory response and disrupt retinal vascular barrier.",
keywords = "Diabetes, HMGB-1, Inflammation, RAGE, Retina, Vascular permeability",
author = "Ghulam Mohammad and Siddiquei, {Mohammad Mairaj} and Amira Othman and Mohamed Al-Shabrawey and {Abu El-Asrar}, {Ahmed M.}",
year = "2013",
month = "2",
day = "1",
doi = "10.1016/j.exer.2012.12.009",
language = "English (US)",
volume = "107",
pages = "101--109",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina

AU - Mohammad, Ghulam

AU - Siddiquei, Mohammad Mairaj

AU - Othman, Amira

AU - Al-Shabrawey, Mohamed

AU - Abu El-Asrar, Ahmed M.

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Extrcellular high-mobility group box-1 (HMGB-1) functions as a pro-inflammatory cytokine and exhibits angiogenic effects. The purpose of this study was to investigate the expression of HMGB-1 signaling pathway components in the retinas of diabetic rats and to examine the effect of intravitreal administration of HMGB-1 on the retinas of rats. The retinas of diabetic and intravitreally injected HMGB-1 rats were studied using immunohistochemistry, Western blotting, co-immunoprecipitation and enzyme-linked immunosorbent assay. The effect of HMGB-1 on retinal endothelial cell barrier function was evaluated using electrical cell-substrate impedance sensing system (ECIS). Diabetes induced significant upregulation of the expression of HMGB-1, receptor for advanced glycation end products (RAGE), ERK1/2 and nuclear transcription factor Kappa B (NF-κB), whereas the expression of toll-like receptor 2 (TLR2) and occludin was significantly downregulated. Co-immunoprecipitation studies revealed significant increase in interaction between HMGB-1 and RAGE. HMGB-1 reduced transendothelial electrical resistance of bovine retinal endothelial cells. Intravitreal administration of HMGB-1 to normal rats induced significant upregulation of intercellular adhesion molecule-1 (ICAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), HMGB-1, RAGE, ERK1/2, and NF-κB, and significantly increased retinal vascular permeability, whereas the expression of TLR2 and occludin was downregulated. Oral administration of glycyrrhizin, a specific inhibitor of HMGB-1, attenuated diabetes-induced upregulation of HMGB-1 expression, NF-κB activation and downregulation of occludin expression. Our findings provide evidence that in the diabetic retina, HMGB-1 possibly interacts with RAGE and activates ERK1/2 and NF-κB to generate an inflammatory response and disrupt retinal vascular barrier.

AB - Extrcellular high-mobility group box-1 (HMGB-1) functions as a pro-inflammatory cytokine and exhibits angiogenic effects. The purpose of this study was to investigate the expression of HMGB-1 signaling pathway components in the retinas of diabetic rats and to examine the effect of intravitreal administration of HMGB-1 on the retinas of rats. The retinas of diabetic and intravitreally injected HMGB-1 rats were studied using immunohistochemistry, Western blotting, co-immunoprecipitation and enzyme-linked immunosorbent assay. The effect of HMGB-1 on retinal endothelial cell barrier function was evaluated using electrical cell-substrate impedance sensing system (ECIS). Diabetes induced significant upregulation of the expression of HMGB-1, receptor for advanced glycation end products (RAGE), ERK1/2 and nuclear transcription factor Kappa B (NF-κB), whereas the expression of toll-like receptor 2 (TLR2) and occludin was significantly downregulated. Co-immunoprecipitation studies revealed significant increase in interaction between HMGB-1 and RAGE. HMGB-1 reduced transendothelial electrical resistance of bovine retinal endothelial cells. Intravitreal administration of HMGB-1 to normal rats induced significant upregulation of intercellular adhesion molecule-1 (ICAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), HMGB-1, RAGE, ERK1/2, and NF-κB, and significantly increased retinal vascular permeability, whereas the expression of TLR2 and occludin was downregulated. Oral administration of glycyrrhizin, a specific inhibitor of HMGB-1, attenuated diabetes-induced upregulation of HMGB-1 expression, NF-κB activation and downregulation of occludin expression. Our findings provide evidence that in the diabetic retina, HMGB-1 possibly interacts with RAGE and activates ERK1/2 and NF-κB to generate an inflammatory response and disrupt retinal vascular barrier.

KW - Diabetes

KW - HMGB-1

KW - Inflammation

KW - RAGE

KW - Retina

KW - Vascular permeability

UR - http://www.scopus.com/inward/record.url?scp=84871965375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871965375&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2012.12.009

DO - 10.1016/j.exer.2012.12.009

M3 - Article

C2 - 23261684

AN - SCOPUS:84871965375

VL - 107

SP - 101

EP - 109

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

ER -